comparemela.com
Latest Breaking News On - Phase 1 skybridge trial nct05652686 - Page 1 : comparemela.com
FDA Grants Fast Track Designation to PT217 for Extensive Stage Small Cell Lung Cancer
The FDA has granted fast track designation to PT217 for patients with extensive stage small cell lung cancer with disease progression.
Ming-wang
Phanes-therapeutics
Fda
Extensive-stage-small-cell-lung-cancer-es-sclc
Lung-cancer
Pt217-
Phase-1-skybridge-trial-nct05652686-
vimarsana © 2020. All Rights Reserved.